Biocryst Pharmaceuticals (BCRX) Capital Leases (2015 - 2026)
Biocryst Pharmaceuticals' Capital Leases came in at $849,000 for Q2 2026, down 58.4% from $2.04 million a year earlier and down 27.6% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Capital Leases (2015 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals' Capital Leases was $1.44 million, down 32.2% from FY2024.
- Capital Leases carries a five-year compound annual growth rate of -17.9% (FY2020 to FY2025).
- Going back by year, Capital Leases was $2.12 million in FY2024 (-25.3%), $2.85 million in FY2023 (+60.1%) and $1.78 million in FY2022.
- The Q2 2026 figure represents the lowest quarterly Capital Leases in data going back to Q4 2015.
- Year-over-year, Capital Leases has declined for seven consecutive quarters, with an average decline of 27.5% over the last seven quarters.
- The fastest year-over-year change in Capital Leases over five years came in Q4 2023 (growth of 60.1%), and the weakest in Q2 2026 (a decline of 58.4%).
- Business Quant data shows BCRX's Capital Leases at $1.17 million (Q1 2026), $1.44 million (Q4 2025) and $1.74 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.50 Bn | 1,103.09 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.20 Bn | 534.73 Bn | 17.26 Bn |
| 3 | AbbVie | 500.82 Bn | 473.93 Bn | 12.70 Bn |
| 4 | Merck | 367.31 Bn | 321.69 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.77 Bn | 261.76 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.35 Bn | 235.04 Bn | 12.86 Bn |
| 7 | Amgen | 235.40 Bn | 190.80 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.59 Bn | 164.79 Bn | 6.22 Bn |
| 9 | Pfizer | 169.39 Bn | 116.04 Bn | 10.94 Bn |
| 10 | Biocryst Pharmaceuticals | 1.98 Bn | 900.00 Mn | 214.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 849,000.00 |
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.44 Mn |
| Sep 30, 2025 | 1.74 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 2.85 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2021 | 5.04 Mn |
| Jun 30, 2021 | 4.10 Mn |
| Mar 31, 2021 | 3.88 Mn |
| Dec 31, 2020 | 3.87 Mn |
| Sep 30, 2020 | 3.92 Mn |
| Mar 31, 2020 | 3.73 Mn |
| Dec 31, 2019 | 3.41 Mn |
| Dec 31, 2018 | 2.70 Mn |
API Access
Biocryst Pharmaceuticals Capital Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-leases&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-leases", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-leases&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();